SiteMap

Normal Text

Large Text

About Us

Membership

BHPR

Education and Events

Sections

Journal

Publications

Guidelines

Media Centre

Public Affairs

Personal tools

You are not logged in
Log in
Register

You are here: Home » Guidelines » Clinical Guidelines: Rheumatoid Arthritis » BSR Statement on Rituximab for Refractory RA

Home

Clinical Guidelines: Rheumatoid Arthritis

Training and Service Provision Guidelines

RCP Guidelines

Clinical Guidelines: Ankylosing spondylitis

Clinical Guidelines: Psoriatic Arthritis

Clinical Guidelines: Other Topics

Log in

Forgotten password

Register

BSR Statement on Rituximab for Refractory RA

Document Actions

13 November 2006

Click here to get the file

Size 28.3 kB - File type application/pdf

Created by sally
Last modified 13 Nov 2006 11:54

Alerts

24 Nov 2008

NICE Appraisal for adalimumab, etanercept and infliximab for RA after failure of a previous anti-TNF

More...

NLH Musculoskeletal News

Teen sport protects bones

Thu, 24 Dec 2009

NICE interventional procedures consultation - Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD)

Wed, 31 Dec 2008

NPCi blog - Glitazones double the risk of bone fracture in women

Mon, 22 Dec 2008

CHMP recommends approval of mifamurtide (Mepact) for osteosarcoma

Fri, 19 Dec 2008

CHMP recommends approval of lasofoxifene (Fablyn) for post-menopausal osteoporosis

Thu, 18 Dec 2008

news from the National Library for Health

Forthcoming Events

08 May 2009

NeuroEndocrine Immunology in Rheumatic Diseases- translation from basics to clinics

Santa Marherita Ligure - Genova, Italy,

More events...